JPS5929563B2 - Red blood cell fractionation and purification method - Google Patents
Red blood cell fractionation and purification methodInfo
- Publication number
- JPS5929563B2 JPS5929563B2 JP51101145A JP10114576A JPS5929563B2 JP S5929563 B2 JPS5929563 B2 JP S5929563B2 JP 51101145 A JP51101145 A JP 51101145A JP 10114576 A JP10114576 A JP 10114576A JP S5929563 B2 JPS5929563 B2 JP S5929563B2
- Authority
- JP
- Japan
- Prior art keywords
- red blood
- blood cells
- adsorbent
- blood
- blood cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明は血液中から白血球・白小板を除去して赤血球を
分画・精製する方法に関するもので、特に成分輸血ある
いは生化学検査において、白血球・血小板を含まない赤
血球の調製法とその装置を提供することを目的とするも
のである。Detailed Description of the Invention The present invention relates to a method for removing white blood cells and platelets from blood to separate and purify red blood cells. The purpose of this invention is to provide a preparation method and an apparatus for the same.
従来、輸血においては全血を用いる場合が多かつたが、
最近は医療の進歩に併つていわゆる成分輸血と呼ばれる
必要な成分だけを輸血する治療法が国内外において進め
られている。Traditionally, whole blood was often used in blood transfusions, but
Recently, along with medical advances, a treatment method called component transfusion, in which only the necessary components are transfused, is being promoted both domestically and internationally.
然るに赤血球の成分輸血において、HL−A型抗原を有
する白血球および血小板抗原を有する血小板を完全に除
去する優れた方法がないために、必ずしも赤血球輸血が
頻繁に行なわれているとは限らない。また、赤血球の生
化学的機能試験においても他の血球成分の混在は良い結
果をもたらさない。輸血を目的とした赤血球の分画法の
公知技術としては次のような方法がある。However, red blood cell transfusions are not always carried out frequently because there is no excellent method for completely removing leukocytes containing HL-A antigens and platelets containing platelet antigens. Also, in a biochemical function test of red blood cells, the presence of other blood cell components does not yield good results. Known techniques for fractionating red blood cells for the purpose of blood transfusion include the following methods.
すなわち、(1)到立遠心分離法 (2)生理食塩水洗
浄法 (3)デキストランまたはHESによる赤血球沈
降法 (4)ナイロンカラム通過法 (5)解凍赤血球
浮遊液の調製〔プラット コンポーネント テエラピー
、アメリカン アソシエーシヨン オブ プラットパン
クズ刊、ツウエンテイース センチユリ−プレスU、5
、A(BloodComponentTherapy7
、AmericanAssociationofBlo
odBanks、、TwentythCenturyP
ressU、S、A)、9−13頁 1969年;日本
赤十字血液センター業務規準 昭和50年;血液成分輸
血時代要覧 大阪赤十字センター刊 昭和50年〕があ
り、この中で(3)は白血球除去赤血球「日赤」として
実際に行なわれているが、いずれも赤血球の回収および
白血球・血小板の除去に関しては満足されるものではな
い。また上記(4)の如き吸着体をカラムにつめて行な
う方法として木綿および木綿糸を用いる方法〔フレミン
グ(Flemimg)、ブリテイツシユ ジャーナル
オブ エキスペリメンタル パソロジー(Britis
hJournalofExperimentalPat
halogy)、7巻281頁、1926年;デイペン
ホルスト(Diepenhorst)ら、ボックス サ
イグイニス(VoxSang、)、23巻 308−3
20頁、1972年〕、ダヌロン繊維を用いる方法〔ラ
ングフエルダー(Langfelder)ら、ボックス
サイグイニス(VoxSamg、)、19巻57頁、
1970年〕があるが、血小板や白血球の中のリンパ球
の分離、′が良好でないし、血液量に対し吸着体の量が
多く赤血球の回収が充分行なわれない。Namely, (1) centrifugation method (2) saline washing method (3) erythrocyte sedimentation method using dextran or HES (4) nylon column passage method (5) Preparation of thawed red blood cell suspension [Platt Components Therapy, American Published by Association of Pratt Punks, Centennial Press U, 5
,A(BloodComponentTherapy7
, American Association of Blo.
odBanks,,TwentythCenturyP
ressU, S, A), pp. 9-13 1969; Japanese Red Cross Blood Center Business Standards 1975; Blood Component Transfusion Era Handbook Published by Osaka Red Cross Center 1975], in which (3) is white blood cell-depleted red blood cells. Although it is actually carried out under the name "Japanese Red Cross Red Blood Cell", neither method is satisfactory in terms of collecting red blood cells and removing white blood cells and platelets. In addition, as a method of packing an adsorbent into a column as described in (4) above, a method using cotton and cotton thread [Flemimg, British Journal]
of Experimental Pathology (Britis)
hJournalofExperimentalPat
Diepenhorst et al., Vox Sang, Vol. 7, p. 281, 1926; Vox Sang, Vol. 23, 308-3
20, 1972], a method using Danelon fibers [Langfelder et al., Vox Samg, Vol. 19, p. 57;
1970], but the separation of lymphocytes from platelets and white blood cells is not good, and the amount of adsorbent is too large compared to the amount of blood, making it difficult to recover red blood cells sufficiently.
中尾ら〔ネイチャー ニュー パイオロソー(Natu
reNewBiology)、246巻 94頁197
3年〕はヘパリン加全血から陽イオン交換セルロースや
陽イオン交換セフアデツクスを用(・て赤血球を純化し
ているが、イオン交換体が高価であり又マグネシウムイ
オンが不可決であること、そして血液量に対し吸着体の
量が多い等の欠点があり実用的でない。Nakao et al.
reNewBiology), vol. 246, p. 94, 197
3 years], red blood cells were purified from heparinized whole blood using cation-exchanged cellulose or cation-exchanged Cephadex, but ion exchangers were expensive, magnesium ions were impermeable, and blood It has drawbacks such as the amount of adsorbent being large relative to the amount of adsorbent, making it impractical.
一方ライト(Wright)〔ザランセツト(TheL
ancet)、1巻4頁、1926年〕はろ紙に白血球
が吸着することをみとめているが、カルピン(Garv
in)〔ジャーナル オブ エキスペリメンタル メデ
イシン(JOurnalOfExperimental
Medicine)、114巻51頁、1961年)は
ろ紙に対する吸着はさほど大きくないとしている。本発
明者は上記の事情を鑑み鋭意研究した結果、ヒト全血、
赤血球沈層および咄乳動物の血液からセルロース粉末、
結晶セルロース、陰イオン交換セルロースに殆んど完全
に白血球・血小板を付着せしめて赤血球を高純度、かつ
高収率で回収することに成功し本発明を完成するに至つ
た。On the other hand, Wright (TheL)
Ancet), Vol. 1, p. 4, 1926] found that white blood cells were adsorbed to filter paper, but Garv.
in) [Journal of Experimental Medicine
Medicine), Vol. 114, p. 51, 1961) states that the adsorption to filter paper is not so large. As a result of intensive research in view of the above circumstances, the present inventor has found that human whole blood,
Cellulose powder from erythrocyte sediment layer and mammalian blood,
The present invention was completed by successfully recovering red blood cells with high purity and high yield by almost completely adhering white blood cells and platelets to crystalline cellulose and anion exchange cellulose.
本発明の実施において用いる血液としては、ヒト新鮮血
にヘパリン、ACD.CPD等の適当な抗凝固剤を加え
たものおよび赤血球沈層(日赤)であるが、必ずしもこ
れに限定されるものではなく赤血球が浮遊した製剤なら
なんでもよい。The blood used in the practice of the present invention includes fresh human blood, heparin, ACD. These include those containing a suitable anticoagulant such as CPD, and an erythrocyte sedimentation layer (Nisseki), but are not necessarily limited thereto, and any preparation in which red blood cells are suspended may be used.
赤血球沈層を用いる場合は、生理食塩水又は等張のバツ
フア一を1/3〜1/2容加えて用いる。また、本発明
の実施において用(・る吸着体としては、セルロース粉
末、結晶セルロース、陰イオン交換セルロースであり、
例えば山陽国策パルプ製KCフロツク、東洋ろ紙製ろ紙
粉末、旭化成工業製アビセル、ジエチルアミノエチルセ
ルロースなどを挙げることができる。ジエチルアミノエ
チルセルロースの如き陰イオン交換体は0H一型で用い
てもよく、予じめC1一型として用いてもよいが安定性
を考慮して塩型の方が好ましい。これらの吸着体は生理
食塩水で予じめ洗浄して用いる。本発明の実施において
前記吸着体をポリプロピレン製等の硬質プラスチツクで
できたカラムに25ミクロンのオープニングを有するナ
イロンメツシユで支持する。吸着体のカラム−の充填は
、生理食塩水に懸濁した吸着体を流しこみ、場合により
加圧して2〜6111/1Vの割でつめる。吸着体の量
は、血液10077!lに対して10〜50′l!11
の範囲である。吸着体に血液を通したあとの洗浄は、赤
血球の回収率をあげるために行なつた方がよく、洗浄液
は生理食塩水で行なう。洗浄の生理食塩水の量は吸着体
1m1に対し1〜3m1が適当である。カラムを通過せ
しめる時間は5〜120分の範囲で、流速が遅い場合は
1kg/Cd以下の力で加圧して溶出を早めてもよい。
以下の実施例1〜5に示されるように、本発明の方法に
よつてヒト全血、赤血球沈層および咄乳動物の血液から
赤血球を分画した結果、赤血球の回収率は95%以上白
血球、血小板の除去率は99%以上という結果が得られ
た。When using an erythrocyte sedimentation layer, add 1/3 to 1/2 volume of physiological saline or isotonic buffer. In addition, the adsorbents used in the practice of the present invention include cellulose powder, crystalline cellulose, anion exchange cellulose,
Examples include KC floc manufactured by Sanyo Kokusaku Pulp, filter paper powder manufactured by Toyo Roshi, Avicel manufactured by Asahi Kasei Industries, and diethylaminoethyl cellulose. An anion exchanger such as diethylaminoethylcellulose may be used in the OH type or may be used in advance as the C1 type, but in consideration of stability, the salt type is preferred. These adsorbents are washed in advance with physiological saline before use. In the practice of this invention, the adsorbent is supported by a nylon mesh having a 25 micron opening in a column made of hard plastic such as polypropylene. To fill the adsorbent column, the adsorbent suspended in physiological saline is poured into the column, and if necessary, the column is pressurized and packed at a rate of 2 to 6111/1V. The amount of adsorbent is 10,077 blood! 10-50'l for l! 11
is within the range of Washing after passing blood through the adsorbent should be done to increase the recovery rate of red blood cells, and the washing solution should be physiological saline. The appropriate amount of physiological saline for washing is 1 to 3 ml per ml of adsorbent. The time for passing through the column is in the range of 5 to 120 minutes, and if the flow rate is slow, elution may be accelerated by applying pressure with a force of 1 kg/Cd or less.
As shown in Examples 1 to 5 below, as a result of fractionating red blood cells from human whole blood, red blood cell sediment layer, and mammalian blood using the method of the present invention, the recovery rate of red blood cells was more than 95% white blood cells. The results showed that the platelet removal rate was over 99%.
回収された赤血球を走査型電子顕微鏡で観察すると吸着
体に接触する前と全く同一の円盤状を示し、パーパート
法で浸透圧脆弱性とみると吸着体接触前後で全く変化は
なかつた。又、吸着体に接触させたものとさせなかつた
ものとを4℃で1週間保存後、アデノシン−トリリン酸
、2・3−ジホスホグリセン酸の定量を行なつた結果、
定量値に全く差はみとめられなかつた。本発明の方法を
実施するための装置としては、第1図に示すような装置
があり、吸着体5を充填したカラム3に血液バツグ1を
連結して用いる。When the recovered red blood cells were observed under a scanning electron microscope, they showed exactly the same disk shape as before contact with the adsorbent, and when viewed by Perpart's method, there was no change in osmotic fragility before and after contact with the adsorbent. In addition, after storing the samples that were in contact with the adsorbent and those that were not at 4°C for one week, the amounts of adenosine triphosphate and 2,3-diphosphoglycenic acid were determined.
No difference was observed in the quantitative values. As an apparatus for carrying out the method of the present invention, there is an apparatus as shown in FIG. 1, in which a blood bag 1 is connected to a column 3 filled with an adsorbent 5.
ヒト全血あるいは赤血球沈層等の血液製剤は中空針7か
ら導管2を通つて吸着体5が充填されたカラム3に導か
れ白血球・血小板は吸着体5に付着する。そしてこの吸
着体5に付着しない赤血球は導管2を通つて血液バッグ
1に回収される。また、この装置はオートクレーブで1
15℃15分処理して無菌化が可能である。この加熱処
理で変化をうけるものは陰イオン交換体のジエチルアミ
ノエチルセルロースで他のセルロースはこの処理で何ら
影響をうけない。以上説明したように、本発明は低廉な
吸着剤を用いて、ヒト全血あるいは赤血球沈層から組織
抗原を含む白血球・血小板が完全に除かれた成分輸血用
の赤血球の調製が簡単、かつ経済的にできるようにし、
臨床検査用の純粋な赤血球の調製を容易にする等の効果
を生ぜしめるものである。Blood products such as human whole blood or an erythrocyte sedimentation layer are guided from a hollow needle 7 through a conduit 2 to a column 3 filled with an adsorbent 5, and white blood cells and platelets adhere to the adsorbent 5. Red blood cells that do not adhere to the adsorbent 5 are collected into the blood bag 1 through the conduit 2. Additionally, this device can be autoclaved for 1
Sterilization can be achieved by processing at 15°C for 15 minutes. This heat treatment changes diethylaminoethylcellulose, an anion exchanger, and other celluloses are not affected by this treatment. As explained above, the present invention uses an inexpensive adsorbent to easily and economically prepare red blood cells for component transfusion from which white blood cells and platelets containing tissue antigens have been completely removed from human whole blood or red blood cell sediment layers. be able to do so,
This produces effects such as facilitating the preparation of pure red blood cells for clinical tests.
以下、実施例をもつて本発明を具体的に説明する。実施
例 1
KC−フロツクW−50(S)(山陽国策パルプ株式会
社製)0.5yを生理食塩水約5m1に懸濁して、これ
を内容積10m1の25ミクロンのオープニングを有す
るナイロンメツシユ2枚をしいたポリプロピレン製カラ
ムにつめる。The present invention will be specifically described below with reference to Examples. Example 1 KC-Flock W-50 (S) (manufactured by Sanyo Kokusaku Pulp Co., Ltd.) 0.5y was suspended in approximately 5ml of physiological saline, and this was added to a nylon mesh 2 having an internal volume of 10ml and an opening of 25 microns. Pack into a lined polypropylene column.
加圧して吸着体の容積を2.51n1にする。ヘパリン
101U/mlを含むヒト新鮮全血6.0m1を流す。
更に生理食塩赤血
球
I
L?????−?−ー一X?−
赤
而
球
※6meに生理食塩水2m1を加えたものを同時に血球
数を比較した。Pressure is applied to bring the volume of the adsorbent to 2.51 n1. 6.0 ml of fresh human whole blood containing 101 U/ml of heparin is run.
Furthermore, saline red blood cell IL? ? ? ? ? −? -1X? - Blood cell counts were compared at the same time when 2ml of physiological saline was added to 6me red blood cells.
白 而 球 而 小 板 木4.0m1に生理食塩水2.0m1を加えて流す。White So ball So small board Add 2.0 ml of saline to 4.0 ml of wood and drain.
以上実施例1と同様に処理し、血球をカウントした。−
ーーーーー一]−一?−H8IU/mlを加えたもの6
.0m1を流す。The cells were treated in the same manner as in Example 1, and blood cells were counted. −
---One]-One? -H8IU/ml added 6
.. Flow 0ml.
以下実施例1と同様に処理し、血球をカウントした。甲
−? − ]
★る。Thereafter, the same treatment as in Example 1 was carried out, and blood cells were counted. Instep −? − ] ★ru.
これに赤血球沈層(日赤)4.0m1に生野食塩水20
m1を加えて流す。以下実施例1と同様に処理し血球を
カウントした。白
而
球
而
ノl\
板
(東京化成工業株式会社製をCl一型として精製乾燥し
たもの)0.57を生理食塩水約5m1に懸濁し実施例
1と同様にカラムにつめ、赤血球沈層(日赤)4.0m
1に生理食塩水2.0TfL1を加えて流す。Add to this 4.0 ml of erythrocyte sedimentation layer (Japan Red Cross) and 20 ml of raw wild saline.
Add m1 and let it flow. Thereafter, the cells were treated in the same manner as in Example 1, and blood cells were counted. 0.57 of Hakujyukyujinol\ plate (made by Tokyo Chemical Industry Co., Ltd. purified and dried as Cl type 1) was suspended in about 5 ml of physiological saline and packed in a column in the same manner as in Example 1, and the red blood cell sediment layer was added. (Japan Red Cross) 4.0m
Add 2.0 TfL1 of physiological saline to 1 and drain.
以下実施例1と同様に処理し血球をカウントした。Thereafter, the cells were treated in the same manner as in Example 1, and blood cells were counted.
第1図は本発明の方法を実施するための装置の1実施例
を示す図である。
1・・・・・・血液バツグ、2・・・・・・導管、3・
・・・・・カラム、4・・・・・・ナイロンメツシユ、
5・・・・・・吸着体、6・・・・・・分岐管、7・・
・・・・中空針。FIG. 1 shows an embodiment of an apparatus for carrying out the method of the invention. 1... Blood bag, 2... Conduit, 3.
...Column, 4...Nylon mesh,
5...adsorbent, 6...branch pipe, 7...
...Hollow needle.
Claims (1)
ス粉末、結晶セルロース、陰イオン交換セルロースのう
ち少くともひとつから成る吸着体に白血球・血小板を付
着せしめて、混在白血球・血小板を除去することを特徴
とする赤血球の分画・精製方法。1. It is characterized by removing mixed white blood cells and platelets from anticoagulated whole blood or red blood cell sediment layer by attaching white blood cells and platelets to an adsorbent made of at least one of cellulose powder, crystalline cellulose, and anion exchange cellulose. A method for fractionating and purifying red blood cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP51101145A JPS5929563B2 (en) | 1976-08-26 | 1976-08-26 | Red blood cell fractionation and purification method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP51101145A JPS5929563B2 (en) | 1976-08-26 | 1976-08-26 | Red blood cell fractionation and purification method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5374096A JPS5374096A (en) | 1978-07-01 |
JPS5929563B2 true JPS5929563B2 (en) | 1984-07-21 |
Family
ID=14292900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51101145A Expired JPS5929563B2 (en) | 1976-08-26 | 1976-08-26 | Red blood cell fractionation and purification method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5929563B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4331388C2 (en) * | 1993-09-15 | 1997-10-16 | Fraunhofer Ges Forschung | Process for the stabilization and long-term preservation of red blood cells |
-
1976
- 1976-08-26 JP JP51101145A patent/JPS5929563B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS5374096A (en) | 1978-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6063624A (en) | Platelet suspensions and methods for resuspending platelets | |
US4130642A (en) | Method of separating blood cells components | |
Kikugawa et al. | Filter columns for preparation of leukocyte-poor blood for transfusion | |
US4744907A (en) | Blood cell separation | |
US4745053A (en) | Process for producing human interferon and method for assaying the interferon productivity of blood | |
US3607857A (en) | Process of removing acrinol from gamma globulin using siliceous material such as silica gel | |
JPS5929563B2 (en) | Red blood cell fractionation and purification method | |
JPH0326170B2 (en) | ||
JPS5854130B2 (en) | Leukocyte separation method | |
EP0367475A2 (en) | Process for producing haemoglobin concentrate | |
CN106860480A (en) | A kind of blood platelet and the preparation method containing hematoblastic preparation | |
JPS5854131B2 (en) | How to isolate leukocytes | |
JPS5854126B2 (en) | Leukocyte separation material | |
JPH09168585A (en) | Blood bag system | |
Hogan et al. | A simple method for preparing neocyte‐enriched leukocyte‐poor blood for transfusion‐dependent patients | |
JPS5936886B2 (en) | How to isolate white blood cells | |
EP0141939A2 (en) | Method of producing a natural immunoabsorbent | |
Goldmann et al. | A method for preparing buffy coat-poor blood for transfusion | |
JPS5914008B2 (en) | Lymphocyte collection method and device | |
Giddings | The fractionation of factor V from human plasma | |
Thong et al. | The rapid one-step gradient centrifugation procedure for simultaneous isolation of granulocytic and mononuclear leukocytes from human blood: biological, physical and chemical bases | |
JPS6330887B2 (en) | ||
KR820002225B1 (en) | Process for obtaining hepatitis b surface antigen | |
CA1261255A (en) | Process for producing human interferon and method for assaying the interferon productivity of blood | |
RU1790604C (en) | Method of production reagent erilide for coagulogic tests conducting |